WJA
TMO icon

Williams Jones & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Williams Jones & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$67.8M Buy
230,915
+9,136
+4% +$2.52M 1.41% 24
2019
Q1 		$60.7M Buy
221,779
+20,993
+10% +$5.22M 1.34% 26
2018
Q4 		$44.9M Sell
200,786
-6,666
-3% -$1.56M 1.22% 26
2018
Q3 		$50.6M Buy
207,452
+1,399
+0.7% +$322K 1.02% 35
2018
Q2 		$42.7M Buy
206,053
+11,413
+6% +$2.42M 0.94% 41
2018
Q1 		$40.2M Buy
194,640
+5,487
+3% +$1.15M 0.93% 42
2017
Q4 		$35.9M Buy
189,153
+38,223
+25% +$7.32M 0.82% 43
2017
Q3 		$28.6M Buy
150,930
+3,021
+2% +$547K 0.7% 46
2017
Q2 		$25.8M Buy
147,909
+12,957
+10% +$2.18M 0.65% 46
2017
Q1 		$20.7M Buy
134,952
+5,684
+4% +$869K 0.54% 52
2016
Q4 		$18.2M Buy
129,268
+10,398
+9% +$1.53M 0.52% 53
2016
Q3 		$18.9M Sell
118,870
-1,666
-1% -$257K 0.55% 59
2016
Q2 		$17.8M Buy
120,536
+3,515
+3% +$519K 0.55% 59
2016
Q1 		$16.6M Buy
117,021
+13,603
+13% +$1.82M 0.77% 42
2015
Q4 		$14.7M Buy
103,418
+86,006
+494% +$11.5M 0.67% 45
2015
Q3 		$2.13M Buy
17,412
+3,400
+24% +$443K 0.1% 137
2015
Q2 		$1.82M Buy
14,012
+905
+7% +$118K 0.07% 159
2015
Q1 		$1.76M Buy
13,107
+4,335
+49% +$559K 0.07% 164
2014
Q4 		$1.1M Buy
8,772
+321
+4% +$39K 0.05% 185
2014
Q3 		$1.03M Sell
8,451
-871
-9% -$106K 0.05% 167
2014
Q2 		$1.1M Sell
9,322
-4,722
-34% -$556K 0.05% 159
2014
Q1 		$1.69M Buy
14,044
+7,722
+122% +$918K 0.03% 200
2013
Q4 		$704K Buy
6,322
+2,150
+52% +$214K 0.03% 174
2013
Q3 		$384K Buy
4,172
+572
+16% +$51.7K 0.02% 209
2013
Q2 		$305K Buy
+3,600
New +$300K 0.02% 262

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Williams Jones & Associates's TMO Position: Q2 2019 in Review

Williams Jones & Associates increased its Thermo Fisher Scientific (TMO) stake by 4.1% in Q2 2019, buying an estimated $2.52M and bringing the position to 230,915 shares worth $67.8M. The position accounts for 1.41% of the portfolio, ranked #24.

Williams Jones & Associates first reported a position in TMO in Q2 2013 and has held it in 25 quarters since. 1,559 funds tracked by Wall St. Rank hold TMO as of Q2 2019.

  • Williams Jones & Associates held 230,915 shares of Thermo Fisher Scientific worth $67.8M as of Q2 2019.
  • Williams Jones & Associates bought 9,136 Thermo Fisher Scientific shares in Q2 2019, an estimated $2.52M.
  • Thermo Fisher Scientific made up 1.41% of Williams Jones & Associates's portfolio in Q2 2019, its #24 holding.
  • Williams Jones & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 25 quarters since.
  • 1,559 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.